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Different clinical applications, including dentistry, are making increasing demands
on bone grafting material. In the present study we have analysed the viability,
proliferation and growth characteristics of fibroblasts cultured in vitro together
with two different bone grafting materials, NanoBone® and Straumann Bone
Ceramic®, over a period of 24 and 28 days respectively. Viability was measured
at least every 72 hours by using the alamarBlue assay, a test that measures
quantitatively cell proliferation and viability but does not require cell fixation or
extraction. After one week of culture fibroblast viability was as high as in con-
trols for both grafting materials and remained high (> 90%) for the duration of
the experiment. Cell growth was evaluated microscopically. Scanning electron
microscopy revealed a dense fibroblast growth at the surface of both bone graft-
ing materials after three weeks of in vitro culture. Generally, our in vitro analyses
contribute to further insights into cell — scaffold interactions.
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INTRODUCTION
Increasing demands are being made of bone
grafting and replacement materials by many clinical
applications, including surgery, orthopaedics and
dentistry. So far the preferred choice for treating
bone defects is autologous bone obtained from the
patient and usually taken from the iliac crest [1]. The
major advantage of autologous bone is that it does
not activate immune reactions leading to inflamma-
tion and rejection. However, the bone harvesting
process requires surgery in a second body part of
the patient, which may cause additional pain, scar-
ring and discomfort, as well as carrying the risk of
infection, generally seen as a disadvantage in this
procedure. It comes as no surprise, therefore, that
more and more bone grafting and replacement ma-
terials have been developed and have entered the
market. These materials should bear characteristics
which support the wound healing process in general,
but they should also promote natural bone recon-
struction in the defect area by their osteoconductive
and osteoinductive properties.
In vitro culture of cells and bone grafting materi-
als is needed to approve scaffolds before they can be
applied in vivo. The procedure of in vitro culture of
stem cells and bone grafting material is, furthermore,
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regarded as a tool in obtaining autologous bone
ex vivo and is known as “tissue engineering” and
referred to as the “technology of the future” [4, 8].
Whereas the culture of bone is still in an early
stage [10], great progress has been made in, for
example, in vitro culture of skin transplants [5, 7, 9]
and of cartilaginous tissue [2, 6].
In the current study we present data on the in
vitro culture of fibroblasts and two different bone
grafting materials (NanoBone®, Straumann Bone
Ceramic®) which are currently used in clinical appli-
cations, especially for tooth implants.
MATERIAL AND METHODS
Bone grafting materials
NanoBone®. According to the description of the
manufacturer (ARTOSS GmbH), NanoBone is a fully
synthetic, granular, highly porous and nanostruc-
tured bone grafting material produced by a sol-gel
process [3]. It is composed of nanocrystalline, non-
sintered hydroxyapatite and silica gel (SiO2) up to
76% and 24% respectively. During processing nanoc-
rystals of this material become tidily connected but
form interconnecting pores of different sizes. The
smallest pores are of a nanometre in diameter. Nano-
Bone® acts osteoinductively and is biocompatible and
biodegradable.
Straumann Bone Ceramic®. According to the
manufacturer’s description (Straumann Biologics®),
Straumann Bone Ceramic® is a fully synthetic bone
graft material of medical grade purity in particulate
form (400–700 µm) and commercially available. It is
a biphasic calcium phosphate composed of 60%
hydroxyapatite and 40% beta-tricalciumphosphate.
It is up to 90% porous with interconnecting pores of
100–150 microns in diameter, biocompatible as well
as resorbable and replaced by vital bone during bone
remodelling.
Cell culture. Human fibroblasts (HFIB; oligene)
and mice connective tissue fibroblasts (L-929; DSMZ
GmbH Germany) were cultured in flasks (25 cm2) with
a culture medium (CM) consisting of RPMI-1640
medium (PAA) containing 5% foetal calf serum (FBS;
GIBCO) and antibiotics (10.000 U/ml penicillin;
10.000 µg/ml streptomycin) for 2 days at 37°C and
5% CO2. The confluent cell monolayer was harvest-
ed by adding trypsin (PAA) for 2 min at room tem-
perature. The detached cells were washed twice
(7 min; 1500 rpm) in PBS (PAA). Viability was checked
by using trypan blue. Cell titer was determined by
using a Neubauer chamber.
1 × 104 fibroblasts per well were added to cul-
ture plates containing bone grafting material and
incubated for 24 or 28 days respectively at 37°C and
5% CO2 in CM. Every third day viability/proliferation
was analysed for treated and control cells by using
the alamarBlue assay and fresh CM was added.
AlamarBlue assay. The alamarBlueTM assay mea-
sures quantitatively cell proliferation as well as rela-
tive cytotoxicity. It incorporates a water soluble col-
orimetric oxidation-reduction (Redox) indicator that
changes colour in response to the chemical reduc-
tion of the culture medium resulting from cell growth
(metabolic activity).
One hundred microlitres of indicator (0.4 ml
alamarBlue stock solution diluted in 10 ml CM) were
added to each test well and incubated for 4 hours at
37°C, 5% CO2. Eighty µl of the culture supernatant
were transferred to a fresh 96 well plate and read
spectrophotometrically to monitor absorbance by
570 nm (reduction) and 630 nm (oxidation).
Relative cytotoxicity was calculated on the basis
of the difference between the treated and the con-
trol cells by using the following formula:
(eox)l2Al1 – (eox)l1Al2 of the test agent dilution
(eox)l2A°l1 – (eox)l1A°l2 of untreated positive
growth control
eox — molar extinction coefficient of alamarBlue in
oxidised form
A — absorbance of test well
A — absorbance of positive growth control well
l1 — 570 nm
l2 — 630 nm
SEM
Fibroblasts incubated with or without bone
grafting material as well as bone grafting materi-
als were analysed by scanning electron microsco-
py after in vitro culture. Cells and bone grafting
material were fixated by glutaraldehyde (2.5% in
CM without FBS and antibiotics) for 2 h at 4°C,
incubated in 1% tannin for 1 h at 4°C and then
dehydrated by ethanol and finally processed in a
critical point drying. Samples were examined us-
ing a digital scanning microscope (DSM 940A;
ZEISS Oberkochen).
Statistics
Data presented result from at least three tests
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RESULTS
Viability
L-929 cells co-cultured with Straumann Bone
Ceramic. Mice fibroblasts (L-929) were co-cultured
with Straumann Bone Ceramic over a period of about
28 days. Fibroblast viability was checked by using
the alamarBlue assay at the days displayed in Figure 1A
and in comparison with L-929 cells cultured with-
out bone grafting material. The metabolic activity
of L-929 cells was decreased in the presence of graft-
ing material at day 2 of cell culture. At day 4 of cul-
ture their metabolic activity had already reached 80%
of that of control cells and about 100% at day 14.
Cell viability remained high (> 90%) until the exper-
iment was terminated at day 28 (Fig. 1A).
Human fibroblasts co-cultured with Nano-
Bone. Human fibroblasts were co-cultured with
NanoBone over a period of 24 days and their viabi-
lity analysed by using the alamarBlue test. As for
L-929 cells in the presence of bone ceramic, a de-
crease in viability was recorded for human fibroblasts
in the presence of NanoBone at day 2 (60%) and day
7 (70%). At day 9 the viability was as high as in the
controls. A cell viability of about 95% was measured
until the end of the experiment at day 24 (Fig. 1B).
Scanning electron microscopy. L-929 cells and
human fibroblasts differ in their morphology as
shown in Figures 2C–F and 3C–F. However both
fibroblast types grew and proliferated at the sur-
face of the bone grafting material added to the
culture, Straumann Bone Ceramic and NanoBone
respectively.
The surface of Straumann Bone Ceramic is struc-
tured as seen in Figures 2A and B, but apparently
not as much as NanoBone (Fig. 3A). Moreover Nano-
Bone has micropores and nanopores (Fig. 3B), which
may allow cells but also growth factors to get deep
into the grafting material. After 24 days of culture
NanoBone was covered by a nearly homogenous lay-
er of human fibroblasts, where single cells were bare-
ly distinguishable.
L-929 cells grow in several layers. Their morphol-
ogy is mainly fibroblast-like but in areas of high cell
density they appear as round cells (Fig. 2C, D). Both
types show several cell processes and some are in-
terconnecting neighbour cells. This phenomenon can
be observed at the surface of bone grafting material
but also at the surface of a glass cover slip (Fig. 2E, F).
The cells at the surface of NanoBone are charac-
terised by long thin processes, which are often con-
nected and give the impression of a three-dimen-
sional network (Fig. 3E, F).
DISCUSSION
Human fibroblasts as well as those from mice
(L-929) can be cultured in vitro and remain viable
for several weeks. From an overall view of the exper-
iments, the bone grafting material does not affect
cell viability. Nevertheless, the metabolic activity of
cells cultured together with bone grafting material
is reduced compared to that of control cells for
a period of one to four days. This may be evidence
of a lower proliferation rate of fibroblasts in the pres-
ence of bone grafting material and might be due to
surface characteristics. Differences in cell spreading
Figure 1. Viability of mice (L-929 cells) and human fibroblast cultured in vitro together with Straumann Bone Ceramic (A) and NanoBone
(B) respectively for more than three weeks. Viability was measured as metabolic activity by using the alamarBlue assay. Viability is ex-
pressed as a percentage compared to control cells cultured without bone grafting material.
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Figure 2. Scanning electron micrographs of Straumann Bone Ceramic cultured in vitro without (A–B) and together with L-929 cells (C–D)
for 28 days. L-929 cells cultured in vitro on glass cover slips for 10 days and 48 hours are shown in E and F respectively. Scale bars are
given in the lower right corner of the micrographs.
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Figure 3. Scanning electron micrographs of NanoBone cultured in vitro without (A–B) and together with human fibroblasts for 24 days
are shown at different magnifications (C–F). Arrows in Figure 3B indicate nanopores in NanoBone. Scale bars are given in the lower right
corner of the micrographs.
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and proliferation are also known for plastic and glass-
bottom wells used for cell culture.
It cannot be assumed that there is a toxic effect
of the grafting materials upon fibroblasts, since ear-
lier experiments using different amounts of Nano-
Bone did not display a dose-dependent effect [11].
After one week of culture viability was as high as in
controls for both grafting materials and remained
high (> 90%) for the duration of the experiment.
Cells proliferated at the surface of the both bone
grafting materials, since the surfaces were densely
covered by fibroblasts after three weeks of culture,
as visualised by SEM (Fig. 2C, D, 3C–F).
Fibroblast growing behaviour and proliferation
cannot be compared directly for both bone grafting
materials, since different cell lines were used in the
experiments. However, interconnecting cellular pro-
cesses were seen for both types of fibroblast. Hu-
man fibroblasts at NanoBone seem to produce longer
fibrils, more intercellular substance and develop
a network, where borders of single cells are hard to
distinguish (Fig. 3B–D).
It would be preferable for human cells to be used
in further studies and these may contribute to a better
understanding of the interactions between cells and
bone grafting materials in vitro and in vivo. These data
could deliver further insights, especially valuable with
respect to tissue engineering,  which is gaining increas-
ing attention and is currently progressing [5, 7, 8, 10].
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